Alphatec Holdings, Inc.
Close on Oct 19, 2026
- Market cap
- $1.63B
- P/E (TTM)
- –
- Dividend yield
- –
About Alphatec
Surgical & Medical Instruments & Apparatus, SIC 3841
Alphatec Holdings, Inc. is a medical technology company that designs, develops, and advances surgical technologies for the treatment of spine disorders. Its product portfolio includes approach-based surgical systems, posterior fixation systems, porous titanium implants, and biologics, alongside solutions for cervical and spinal deformity conditions. The company also provides intraoperative nerve-monitoring technology and full-body calibrated three-dimensional imaging platforms with procedural planning software. Its primary customers include spine surgeons, hospitals, and healthcare systems.
The company is based in Carlsbad, California, where it maintains its corporate headquarters and an educational facility equipped with a cadaveric laboratory. It also operates a distribution facility located in Memphis, Tennessee. Alphatec conducts its operations primarily within the United States, while its clinical imaging systems are utilized across specialized medical centers globally. The business distributes its spine solutions through a commercial sales network comprising direct representatives and independent sales agents.
Summary of the business section of Alphatec's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Alphatec Holdings, Inc.
- Headquarters
- Carlsbad, CA
- Address
- 1950 Camino Via Roble
- Phone
- (760) 431-9286
- Employees
- 913, Dec 31, 2025
- Industry
- Surgical & Medical Instruments & Apparatus
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- Deloitte & Touche LLP, New York, New York, United States
Stock & identifiers
- Ticker
- ATEC
- Exchange
- Nasdaq
- IPO date
- Jun 5, 2006
- Shares outstanding
- 154M, Jul 28, 2026
- Public float
- $1.30B, Jun 30, 2025
- Filer category
- Large accelerated filer
- Stock splits
- 1-for-12 reverse, Aug 25, 2016; 1-for-12 reverse, Aug 24, 2016
- SEC CIK
- 1350653
- CUSIP
- 02081G201
- ISIN
- US02081G2012
- LEI
- 549300EZE8CQ8K65FS24
- EIN
- 20-2463898
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Patrick Miles | CEO, Director | 6,154,451 |
| Thomas Andrew Carls | EVP, Data & Imaging Solutions | 2,520 |
| Tyson Eliot Marshall | GENERAL COUNSEL & CORP. SEC. | 630,398 |
| John Todd Koning | CHIEF FINANCIAL OFFICER | 600,721 |
| Scott Lish | CHIEF OPERATING OFFICER | 815,704 |
| David Sponsel | EVP, SALES | 504,932 |
| Craig E. Hunsaker | EVP, PEOPLE & CULTURE | 1,725,609 |
| Karen K. McGinnis | Director | 94,671 |
| David R. Pelizzon | Director | 10,773,884 |
| Keith Valentine | Director | 264,283 |
| Quentin S. Blackford | Director | 600,381 |
| Mortimer Berkowitz III | Director | 1,261,164 |
| David M. Demski | Director | 431,635 |
| Jeffrey P. Rydin | Director | 385,441 |
| Ward W. Woods Jr | Director | 2,210,602 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 Patrick S. Miles | $10.26M | $29.73M | $4.84M | $192 | $155 |
| FY2024 Patrick S. Miles | $6.22M | $4.06M | $2.85M | $25 | $73 |
| FY2023 Patrick S. Miles | $9.48M | $23.34M | $3.43M | $108 | $124 |
| FY2022 Patrick S. Miles | $5.95M | $7.37M | $2.28M | $69 | $99 |
| FY2021 Patrick S. Miles | $5.27M | $8.27M | $2.84M | $56 | $138 |
| FY2020 Patrick S. Miles | $4.68M | $23.64M | $1.48M | $205 | $122 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Employees
Headcount reported in annual reports
“As of December 31, 2025, we had 913 employees worldwide.”
Corporate history
Events identified from SEC filings